The compound appears to work by increasing intracellular NAD+ levels (through preventing nicotinamide consumption by NNMT), which activates sirtuins and enhances mitochondrial function and fatty acid oxidation, while also promoting a phenomenon called "browning" of white adipose tissue - the transformation of energy-storing white fat cells into metabolically active beige/brown adipocytes that burn fatty acids for thermogenesis rather than storing them
Current research involving IGF-1 LR3 remains limited to non-clinical settings, where investigators examine its interaction with IGF-1 receptors, along with its influence on intracellular signaling pathways and downstream biological mechanisms
The overall side effect burden tends to be lower with tirzepatide for most researchers
The Canadian research community has increasingly explored these combinations, particularly as weight loss medications become more accessible
Serum antioxidant levels, particularly CoQ10 and vitamin C, are also decreased in FM patients, further impairing the body's ability to counteract oxidative damage (16)
This synergy enhances detoxification, pigmentation control, and cellular protection
